Cargando…
miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease
The neuropathology of Alzheimer’s disease (AD) is characterized by intracellular aggregation of hyperphosphorylated tau and extracellular accumulation of beta-amyloid (Aβ). Death-associated protein kinase 1 (DAPK1), as a novel therapeutic target, shows promise for the treatment of human AD, but the...
Autores principales: | Wang, Long, Shui, Xindong, Mei, Yingxue, Xia, Yongfang, Lan, Guihua, Hu, Li, Zhang, Mi, Gan, Chen-Ling, Li, Ruomeng, Tian, Yuan, Wang, Quling, Gu, Xi, Chen, Dongmei, Zhang, Tao, Lee, Tae Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317260/ https://www.ncbi.nlm.nih.gov/pubmed/35887339 http://dx.doi.org/10.3390/ijms23147992 |
Ejemplares similares
-
Blocking ERK-DAPK1 Axis Attenuates Glutamate Excitotoxicity in Epilepsy
por: Gan, Chen-Ling, et al.
Publicado: (2022) -
Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease
por: Zhang, Tao, et al.
Publicado: (2022) -
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease
por: Chen, Dongmei, et al.
Publicado: (2022) -
Inhibition of Death-associated Protein Kinase 1 protects against Epileptic Seizures in mice
por: Gan, Chen-Ling, et al.
Publicado: (2021) -
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
por: Zhao, Jing, et al.
Publicado: (2020)